Navigation Links
Jazz Pharmaceuticals Announces Third Quarter 2009 Financial Results
Date:11/5/2009

PALO ALTO, Calif., Nov. 5 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced financial results for the third quarter ended September 30, 2009.

Total revenues for the third quarter of 2009 were $30.8 million, compared to $17.7 million for the quarter ended September 30, 2008. XYREM® (sodium oxybate) oral solution net sales for the third quarter of 2009 were $25.0 million, compared to $14.2 million for the third quarter of 2008, and represented a 12% sequential increase over net sales of $22.4 million for the second quarter of 2009. Net sales of once-daily LUVOX CR® (fluvoxamine maleate) extended-release capsules were $5.0 million for the third quarter of 2009, compared to $2.0 million for the third quarter 2008, and represented a 20% sequential increase over net sales of $4.1 million for the second quarter of 2009. Total revenues for the third quarter of 2009 also included $0.8 million in royalties and contract revenue.

"Our sales team delivered another solid quarter for us with record numbers of XYREM and LUVOX CR prescriptions and net sales" said Bob Myers, President of Jazz Pharmaceuticals.

Research and development expenses for the third quarter of 2009 were $7.6 million, compared to $12.1 million for the third quarter of 2008. This reduction from $11.2 million for the second quarter of 2009 was primarily due to the completion of the second Phase III pivotal clinical efficacy trial for JZP-6, sodium oxybate for the treatment of fibromyalgia, in June of 2009. Jazz Pharmaceuticals expects to submit a New Drug Application for JZP-6 by the end of 2009.

Jazz Pharmaceuticals' net loss for the third quarter of 2009 was $1.7 million, compared to a net loss of $28.8 million for the third quarter of 2008.

Jazz Pharmaceuticals is increasing its full-year 20
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...EWYORK,Nov.25/PRNewswire/--Reportlinker.comannounc...logue: ,, MammographyEquipment-AGlobalMarketP...164330/Mammography-Equipment---A-Global-Market-Per...inindustrializedaswellasdevelopingnationsisaprinci...lobally,escalatingawarenessaboutbreastcancerhasall...
(Date:11/25/2009)...ANDIEGO,Nov.25/PRNewswire-FirstCall/--NuVasive,Inc...elopingproductsforminimallydisruptivesurgicaltreat...erencecallonMonday,November30,2009,at5:30p.m.ET/2:...relativetoreimbursementfortheCompany,sproductsandw...estionandanswersession.Thedial-innumbersare1-877-4...
(Date:11/25/2009)...ELFT,TheNetherlandsandJOHANNESBURG,November25/PRNe...dPyxisDiscoveryannouncedtoday,thattheyhavesignedac...,services. , Pyxis,sworldclasscomputationalch...iThemba,sservicedivisiontoprovidemedicinaland,synt...xis,internationalclientnetwork.iThembaPharmaceuti...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Online Banners Yield High Click Through Rate For NAS Texas Healthcare Client 48249 1Online Banners Yield High Click Through Rate For NAS Texas Healthcare Client 48249 2Anesthesia Can Make Patients Vomit After Cosmetic Surgery World 26apos 3Bs Top Expert Says PK Anesthesia Is Better 48247 1Anesthesia Can Make Patients Vomit After Cosmetic Surgery World 26apos 3Bs Top Expert Says PK Anesthesia Is Better 48247 2Anesthesia Can Make Patients Vomit After Cosmetic Surgery World 26apos 3Bs Top Expert Says PK Anesthesia Is Better 48247 3Studies Highlight a Revolutionary New Method of Treating Post Operative Bruising 48245 1Studies Highlight a Revolutionary New Method of Treating Post Operative Bruising 48245 2Studies Highlight a Revolutionary New Method of Treating Post Operative Bruising 48245 3Studies Highlight a Revolutionary New Method of Treating Post Operative Bruising 48245 4
...howed 11 Percent Fewer RA Patients,Reported Job Lo...mpared to Methotrexate Alone, BARCELONA, Spain, Ju...rthritis (RA) is one of the most common causes of,... today show that,rheumatoid arthritis (RA) patient...yed working longer, had fewer absences and reporte...
..., 2007 /PRNewswire-FirstCall/ --,Genzyme Corp. tod...ing a powder form of Renvela (sevelamer carbonate)...luding one trial in which,patients received the po... was administered once per day. , Genzyme is devel...nal option for patients with chronic kidney diseas...
Other Medicine Technology:Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 2Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 3Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 4Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 5Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 6Three Studies Suggest Abbott's Humira (adalimumab) May Improve Work,Productivity in Patients with Rheumatoid Arthritis 7Genzyme Announces Results of Clinical Trials Investigating Powder,Form of Sevelamer Carbonate 2Genzyme Announces Results of Clinical Trials Investigating Powder,Form of Sevelamer Carbonate 3Genzyme Announces Results of Clinical Trials Investigating Powder,Form of Sevelamer Carbonate 4Genzyme Announces Results of Clinical Trials Investigating Powder,Form of Sevelamer Carbonate 5
(Date:11/26/2009)...oo heavy can lead to strains or worse , ,...be nothing wrong with stuffing your turkey full to...hing with your suitcase as you pack for holiday tr...2008 in U.S. hospital emergency rooms, doctors, of...ggage-related injuries, such as muscle strains, pu...
(Date:11/26/2009)...o more letters from the North Pole, Textsanta.net ...s from Santa , North Pole...al efficiencies at the North Pole Santa Claus has ... over the globe informed of his Christmas progress...earch department have identified a large and growi...
(Date:11/26/2009)...esearch Triangle Dental (RTDental), a leading dent... announced the expansion of its services to includ...oug Macmillan. , Durha...ed to announce that Dr. Doug Macmillan, an experie...ditional advanced training seminar. RTDental&rsqu...
(Date:11/26/2009)...nnis & Ennis, P.A. is offering free nationwide...asmin birth control pills who have suffered a Deep..., Heart Attack or other related cardiac issues or ... free at 1-800-856-6405 or go to the firm’s ...an online case evaluation form. , ...
(Date:11/25/2009)...25/PRNewswire/--TheBartleHallConventionCenterwillt...ec.9-10,whenKansasCityhoststhelatestinaseriesofmas...cliniceventhasthepotentialtobethebiggestoneyet,bec...ldonweekdaysinsteadofoveraweekend,"SheriWood,execu...identoftheNationalAssociationofFreeClinics(NAFC). ...
Breaking Medicine News(10 mins):Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Kansas City Prepares for Largest Free Health Clinic 2
...hed in the Lancet has brought to light that diabet...Indian //community. With only 2.2percent of the Ad... obese this clearly shows that the Indian body con...etes. And by the year 2025 diabetes would be preva...
...ciation (1) is offering Indian companies the oppor...ness// seminar and business speed dating event, wh... keen to expand into the United Kingdom pharmacy m...7, will be the largest gathering of chain retail p...
... Soy Trial (BEST), a Baltimore-based randomized co...y of results// pertaining to cholesterol reduction... trials. The multi-disciplinary study team, ... in Menopause and Ethnicity and Disease and today ...
...heat and humidity that lead to dehydration can sig...to research presented this week at the American// ...in Washington DC. Gout, caused by deposits o...most often the big toe, can also generate fever, c...
...opportune time to evaluate the support available t...d coping with a galloping disease. Taking// cogniz...- 'Diabetes Care for Everyone, especially the disa...ttention towards the communities and groups in bot...
...opulation based study conducted in Sweden points o...e, a disease which is caused as a result of allerg...wheat can cause them to become triple times more ...or Dr. Jonas F. Ludvigsson told media that there a...
Other Medicine News:Health News:A Hot Date with the Lucrative UK Pharma Market 2Health News:Soy Protein Study Generates New Findings 2Health News:It's the Heat and the Humidity: How Each Worsens Gout Symptoms 2Health News:The Holy Grail of Diabetes Management 2Health News:The Holy Grail of Diabetes Management 3Health News:From the frying pan into the fire: Celiac disease and diabetes 2
... an advanced ophthalmic system that integrates bot...s to independently select either pump mode for Pha...is futuristic system is a microprocessor-controlle...ure, ensuring precise and linear vacuum control in...
SIL-5000-S® Silicone Oil - Syringe
SIL-5000® Silicone Oil
...y become a practice-changing technology for the as...nt of lower urinary tract symptoms (LUTS). Practic...on , Men unfit for surgery , Waiting list pati...UNA, Brachytherapy, Cryotherapy , LUTS different...
Medicine Products: